PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladie…
Author: Business Wire
Neurotech Granted Permanent J-Code (J3403) for ENCELTO™ (revakinagene taroretcel-lwey), Effective October 1, 2025
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, today announced that the Centers for Medicare & Medicaid Services (CMS) has assig…
AR Breakthrough: SCHOTT achieves serial production of Geometric Reflective Waveguides
RYE BROOK, N.Y.–(BUSINESS WIRE)–International technology group SCHOTT, a leader in high-performance materials and optics, has achieved a breakthrough in high-volume production of Geometric Reflective Waveguides. This marks a key advancement for Augme…
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 29, 2025. The …
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today published a presentation reviewing the compelling,…
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today published a presentation reviewing the compelling,…
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today celebrated the …
Broadwood Partners遞交最終代理聲明，呼籲STAAR Surgical股東投票「反對」Alcon收購提案
紐約–(BUSINESS WIRE)–(美國商業資訊)– 身為STAAR Surgical Company（簡稱「STAAR」或「公司」）(NASDAQ: STAA)約27.5%已發行普通股的持有者，Broadwood Partners, L.P.及其附屬公司（統稱「Broadwood」）今日宣布已向美國證券交易委員會（簡稱「SEC」）遞交最終代理聲明和綠色代理卡，並就反對Alcon Inc. (NYSE: ALC)附屬公司擬按2025年8月5日公布的條款收購公司（簡稱「擬議合併」）一事致信其…
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that …
Horizon Surgical Systems Appoints Rajesh K. Rajpal, MD as Chief Strategy and Medical Officer
SANTA MONICA, Calif.–(BUSINESS WIRE)–Horizon Surgical Systems, a leader in surgical robotic platforms, appoints Rajesh K. Rajpal, MD as its Chief Strategy and Medical Officer (CSO & CMO).
EssilorLuxottica Digital Transformation Analysis Report 2025: Technology Focus and Initiatives, Partnerships, Acquisition Network Map, ICT Budget – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Enterprise Tech Ecosystem Series: EssilorLuxottica SA 2025” company profile has been added to ResearchAndMarkets.com’s offering. The report provides detailed information and insights into EssilorLuxottica’s technology acti…
Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025
JERSEY CITY, N.J.–(BUSINESS WIRE)–Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of 2025’s “Fierce 15” biotechnology companies. The ann…
Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025
JERSEY CITY, N.J.–(BUSINESS WIRE)–Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of 2025’s “Fierce 15” biotechnology companies. The ann…
Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025
JERSEY CITY, N.J.–(BUSINESS WIRE)–Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of 2025’s “Fierce 15” biotechnology companies. The ann…
Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025
JERSEY CITY, N.J.–(BUSINESS WIRE)–Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of 2025’s “Fierce 15” biotechnology companies. The ann…
Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025
JERSEY CITY, N.J.–(BUSINESS WIRE)–Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of 2025’s “Fierce 15” biotechnology companies. The ann…
Retina Consultants of America Expands Network with Addition of The Retina Institute
SOUTHLAKE, Texas–(BUSINESS WIRE)–Retina Consultants of America (RCA), a leading management services organization of retina specialists, today announced the addition of The Retina Institute (TRI) to its nationwide network. The St. Louis-based practice…
Retina Consultants of America Expands Network with Addition of The Retina Institute
SOUTHLAKE, Texas–(BUSINESS WIRE)–Retina Consultants of America (RCA), a leading management services organization of retina specialists, today announced the addition of The Retina Institute (TRI) to its nationwide network. The St. Louis-based practice…
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the 45-day “window sho…
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the 45-day “window sho…